| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 67.392.550 $ | -16.074.271 $ | +14,9 % | 2 | 83.466.821 $ | +83.466.821 $ | 2 | |||||
| Omada Health, Inc. | OMDA | → 0 | Neutral | 65.464.987 $ | -16.717.790 $ | -20,3 % | 1 | 82.182.777 $ | +82.182.777 $ | 1 | |
| Artiva Biotherapeutics, Inc. | ARTV | → 0 | Schwach | 1.927.563 $ | +643.519 $ | +50,1 % | 1 | 1.284.044 $ | +1.284.044 $ | 1 | |
| 67.392.550 $ | -16.074.271 $ | +14,9 % | 2 | 83.466.821 $ | +83.466.821 $ | 2 | |||||